Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.
What can the Yescarta launch teach today's life sciences leaders? Building on Harris Kaplan's In Vivo podcast, this article explores the CAR-T commercialization lessons that continue to shape launch strategy, market access, and real-world adoption.
What determines whether a breakthrough therapy becomes a commercial success? In this Citeline In Vivo podcast, Harris Kaplan joins former Kite Pharma executive Diane Parks and CAR-T patient Jim Haag to discuss the launch of Yescarta and the critical role that stakeholder adoption, market access, and real-world implementation play in translating scientific innovation into lasting impact.
